Loading...
•
Jun 30, 2022
PetMed Express Q1 2023 Earnings Report
PetMed Express reported a decrease in sales and net income for the first quarter of fiscal year 2023, while making strategic investments in infrastructure and partnerships.
Key Takeaways
PetMed Express reported a decrease in sales to $70.2 million compared to $79.3 million in the same period last year, impacted by a slow start to the flea and tick season. Net income also decreased to $2.8 million, or $0.14 diluted earnings per share, compared to $4.4 million, or $0.22 diluted earnings per share, in the prior year. Despite the sales decline, the company saw a rebound in sales from its returning customer base later in the quarter and is focusing on long-term growth through investments in infrastructure, partnerships, and expansion into the broader wellness market.
First quarter sales were $70.2 million, down from $79.3 million in the same period last year, due to a slow start to flea and tick season.
Net income decreased to $2.8 million, or $0.14 diluted earnings per share, compared to $4.4 million, or $0.22 diluted earnings per share, in the prior year.
The company is investing in infrastructure, including processes, systems, and people, to grow long-term shareholder value.
PetMeds is expanding from a primarily existing customer-focused business to include a focus on generating new customers.
Forward Guidance
PetMeds is focused on improvement in new customer growth, continued migration to a recurring subscription model, active deployment of capital, full rollout of pet telemedicine capability, and expansion of product catalog and services.
Positive Outlook
- Expanding and accelerating new customer acquisition efforts.
- Continuing migration of business to a recurring subscription model.
- Leveraging capital to accelerate transformation through investments, partnerships, and acquisitions.
- Executing on the deployment and expansion of integrations and partnership with Vetster.
- Expanding product catalog and services, including a wider product assortment and more health and wellness services.
Challenges Ahead
- It takes time to transform a company, especially in a highly competitive market and in an uncertain economic environment.
- The company saw a slow start to flea and tick season due to seasonally colder temperatures, which continued into the early part of the most recent quarter.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...